
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical gel containing sulfur, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing sulfur is listed. Products containing it are filed in the directory as homeopathic products, over-the-counter monograph drugs and unapproved drugs, in gel, liquid, cream, pellet and solution forms.
Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Sulfur is a topical keratolytic and antimicrobial agent that compounding pharmacies prepare in ointments, creams, lotions and washes for skin conditions.
Sulfur has a long history in dermatology. When applied to skin, it reacts with cysteine in skin cells to form hydrogen sulfide, and it is described as loosening and shedding the outer layer of skin (keratolytic) and having antifungal and broad antimicrobial activity. Sulfur is an active ingredient in nonprescription acne products sold under FDA's OTC acne rules, such as Sulfo-Lo Cleansing Bar Soap (Crown Laboratories), labeled for the management of acne, blackheads and comedones. Dermatology literature describes its use in acne, rosacea, seborrheic dermatitis, scabies and tinea versicolor. A prescriber may order sulfur compounded, for example as precipitated sulfur in a petrolatum ointment or combined with other ingredients, in a strength or base that is not sold over the counter. Compounded preparations are not FDA-approved and require a prescription.
Sulfur is for external use only. Over-the-counter sulfur acne products carry warnings, not a boxed warning: avoid the eyes, do not apply to broken skin or large areas, and expect more dryness and irritation if you use another topical acne medicine at the same time. If irritation occurs, use only one topical acne medicine at a time, and stop and call your prescriber if irritation persists or worsens. If a sulfur product is swallowed, get medical help or contact Poison Control. LactMed states that sulfur in a petrolatum base is considered safe for topical use in children, including infants under 2 months, which makes it an alternative for treating scabies in nursing mothers, although the petrolatum base is not suited to use on the breast. Talk to your prescriber or pharmacist before using it while pregnant or with other skin products.
On skin, sulfur reacts with cysteine in keratinocytes to produce cystine and hydrogen sulfide; the review by Chen et al. attributes exfoliating and anti-inflammatory activity to hydrogen sulfide and antifungal activity to pentathionic acid, and notes sulfur is keratoplastic at low and keratolytic at higher concentrations. The review describes precipitated sulfur, which has a smaller particle size, as preferred over sublimed sulfur in dermatologic formulations. Sulfur is a permitted OTC acne active ingredient, including in combination with resorcinol under 21 CFR 333 Subpart D. Prescribers have ordered compounded sulfur in petrolatum for scabies; StatPearls lists sulfur ointment as an alternative for infants younger than 2 months, for whom permethrin is not approved, with all household contacts treated at the same time. The dermatology review also describes use in rosacea, seborrheic dermatitis and tinea versicolor. Strength, base and duration are per prescriber. Monitor for irritation and dryness, especially with other topical acne agents. Sulfur is not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin and spread it in a thin layer. For a metered pump, your label states the number of presses. For a dosing syringe, push the plunger to the mark. Let the gel dry before covering with clothing. Wash your hands afterward and keep the site from touching other people until it has dried. Do not apply to broken skin unless told to.
A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, away from heat and open flame if it contains alcohol, out of reach of children, and discard after the beyond-use date on your label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
Apply topically to affected area(s) once to twice daily as directed.